Hartmut Glossmann, M.D. - Publications

Affiliations: 
Innsbruck Medical University, Innsbruck, Tirol, Austria 
Area:
Calcium Channels

199 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Murgueitio MS, Henneke P, Glossmann H, Santos-Sierra S, Wolber G. Prospective virtual screening in a sparse data scenario: design of small-molecule TLR2 antagonists. Chemmedchem. 9: 813-22. PMID 24470159 DOI: 10.1002/cmdc.201300445  1
2013 Glossmann HH. Oral supplementation with calcitriol, calcidiol, vitamin D3 or moderate sun exposure? The Journal of Investigative Dermatology. 133: 2648-9. PMID 23639978 DOI: 10.1038/jid.2013.201  1
2013 Hautz T, Krapf C, Grahammer J, Zelger B, Hickethier T, Seger C, Eberhart N, Wallner C, Messner F, Kotsch K, Griesmacher A, Brandacher G, Lee WP, Margreiter R, Pratschke J, ... Glossmann H, et al. Targeting the Kv1.3 potassium channel for immunosuppression in vascularized composite allotransplantation - a pilot study. Transplant International : Official Journal of the European Society For Organ Transplantation. 26: 552-61. PMID 23489391 DOI: 10.1111/tri.12080  1
2013 Glossmann H, Reider N. A marriage of two "methusalem"drugs for the treatment of psoriasisαarguments for a pilot trial with metformin as add-on for methotrexate Dermato-Endocrinology. 5: 252-263. DOI: 10.4161/derm.25111  1
2012 Glossmann HH, Blumthaler M. Does rosuvastatin increase serum levels of 25-hydroxy-vitamin D? Dermato-Endocrinology. 4: 2-7. PMID 22870344 DOI: 10.4161/derm.18681  1
2012 Santos-Sierra S, Kirchmair J, Perna AM, Reiss D, Kemter K, Röschinger W, Glossmann H, Gersting SW, Muntau AC, Wolber G, Lagler FB. Novel pharmacological chaperones that correct phenylketonuria in mice. Human Molecular Genetics. 21: 1877-87. PMID 22246293 DOI: 10.1093/hmg/dds001  1
2011 Glossmann HH. Are all steaks created equal? Public Health Nutrition. 14: 1128. PMID 21382224 DOI: 10.1017/S1368980011000152  1
2011 Glossmann H. Vitamin D, UV, and skin cancer in the elderly: to expose or not to expose? Gerontology. 57: 350-3. PMID 21196703 DOI: 10.1159/000322521  1
2011 Glossmann HH. Pharmacology of vitamin D: Anything new? Osteologie. 20: 299-303.  1
2010 Kickstein E, Krauss S, Thornhill P, Rutschow D, Zeller R, Sharkey J, Williamson R, Fuchs M, Köhler A, Glossmann H, Schneider R, Sutherland C, Schweiger S. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling. Proceedings of the National Academy of Sciences of the United States of America. 107: 21830-5. PMID 21098287 DOI: 10.1073/pnas.0912793107  1
2010 Lagler FB, Gersting SW, Zsifkovits C, Steinbacher A, Eichinger A, Danecka MK, Staudigl M, Fingerhut R, Glossmann H, Muntau AC. New insights into tetrahydrobiopterin pharmacodynamics from Pah enu1/2, a mouse model for compound heterozygous tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency. Biochemical Pharmacology. 80: 1563-71. PMID 20705059 DOI: 10.1016/j.bcp.2010.07.042  1
2010 Glossmann HH. Origin of 7-dehydrocholesterol (provitamin D) in the skin. The Journal of Investigative Dermatology. 130: 2139-41. PMID 20445550 DOI: 10.1038/jid.2010.118  1
2010 Gersting SW, Lagler FB, Eichinger A, Kemter KF, Danecka MK, Messing DD, Staudigl M, Domdey KA, Zsifkovits C, Fingerhut R, Glossmann H, Roscher AA, Muntau AC. Pahenu1 is a mouse model for tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency and promotes analysis of the pharmacological chaperone mechanism in vivo. Human Molecular Genetics. 19: 2039-49. PMID 20179079 DOI: 10.1093/hmg/ddq085  1
2005 Laggner C, Schieferer C, Fiechtner B, Poles G, Hoffmann RD, Glossmann H, Langer T, Moebius FF. Discovery of high-affinity ligands of sigma1 receptor, ERG2, and emopamil binding protein by pharmacophore modeling and virtual screening. Journal of Medicinal Chemistry. 48: 4754-64. PMID 16033255 DOI: 10.1021/jm049073+  1
2003 Wolf M, Eberhart A, Glossmann H, Striessnig J, Grigorieff N. Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. Journal of Molecular Biology. 332: 171-82. PMID 12946355 DOI: 10.1016/S0022-2836(03)00899-4  1
2003 Moebius FF, Fitzky BU, Wietzorrek G, Haidekker A, Eder A, Glossmann H. Cloning of an emopamil-binding protein (EBP)-like protein that lacks sterol delta8-delta7 isomerase activity. The Biochemical Journal. 374: 229-37. PMID 12760743 DOI: 10.1042/BJ20030465  1
2003 Wenger M, Gasser R, Donnemiller E, Erler H, Glossmann H, Patsch JR, Moncayo R, Schirmer M. Images in cardiovascular medicine. Generalized large vessel arteritis visualized by 18fluorodeoxyglucose-positron emission tomography. Circulation. 107: 923. PMID 12591766 DOI: 10.1161/01.CIR.0000050689.89407.87  1
2002 Wappl E, Koschak A, Poteser M, Sinnegger MJ, Walter D, Eberhart A, Groschner K, Glossmann H, Kraus RL, Grabner M, Striessnig J. Functional consequences of P/Q-type Ca2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. The Journal of Biological Chemistry. 277: 6960-6. PMID 11742003 DOI: 10.1074/jbc.M110948200  1
2001 Fitzky BU, Moebius FF, Asaoka H, Waage-Baudet H, Xu L, Xu G, Maeda N, Kluckman K, Hiller S, Yu H, Batta AK, Shefer S, Chen T, Salen G, Sulik K, ... ... Glossmann H, et al. 7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. The Journal of Clinical Investigation. 108: 905-15. PMID 11560960 DOI: 10.1172/JCI12103  1
2001 Koschak A, Reimer D, Huber I, Grabner M, Glossmann H, Engel J, Striessnig J. alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. The Journal of Biological Chemistry. 276: 22100-6. PMID 11285265 DOI: 10.1074/jbc.M101469200  1
2001 Wappl E, Mitterdorfer J, Glossmann H, Striessnig J. Mechanism of dihydropyridine interaction with critical binding residues of L-type Ca2+ channel alpha 1 subunits. The Journal of Biological Chemistry. 276: 12730-5. PMID 11278630 DOI: 10.1074/jbc.M010164200  1
2000 Kitaichi K, Chabot JG, Moebius FF, Flandorfer A, Glossmann H, Quirion R. Expression of the purported sigma(1) (sigma(1)) receptor in the mammalian brain and its possible relevance in deficits induced by antagonism of the NMDA receptor complex as revealed using an antisense strategy. Journal of Chemical Neuroanatomy. 20: 375-87. PMID 11207432 DOI: 10.1016/S0891-0618(00)00106-X  1
2000 Huber I, Wappl E, Herzog A, Mitterdorfer J, Glossmann H, Langer T, Striessnig J. Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. The Biochemical Journal. 347: 829-36. PMID 10769189 DOI: 10.1042/0264-6021:3470829  1
2000 Moebius FF, Fitzky BU, Glossmann H. ErratumGenetic Defects in Postsqualene Cholesterol Biosynthesis. Trends in Endocrinology and Metabolism: Tem. 11: 150. PMID 10754537  0.64
2000 Kraus RL, Sinnegger MJ, Koschak A, Glossmann H, Stenirri S, Carrera P, Striessnig J. Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. The Journal of Biological Chemistry. 275: 9239-43. PMID 10734061 DOI: 10.1074/jbc.275.13.9239  1
2000 Moebius FF, Fitzky BU, Glossmann H. Genetic defects in postsqualene cholesterol biosynthesis. Trends in Endocrinology and Metabolism: Tem. 11: 106-14. PMID 10707051 DOI: 10.1016/S1043-2760(00)00235-6  1
2000 Witsch-Baumgartner M, Fitzky BU, Ogorelkova M, Kraft HG, Moebius FF, Glossmann H, Seedorf U, Gillessen-Kaesbach G, Hoffmann GF, Clayton P, Kelley RI, Utermann G. Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. American Journal of Human Genetics. 66: 402-12. PMID 10677299 DOI: 10.1086/302760  1
1999 Wanner SG, Glossmann H, Knaus HG, Baker R, Parsons W, Rupprecht KM, Brochu R, Cohen CJ, Schmalhofer W, Smith M, Warren V, Garcia ML, Kaczorowski GJ. WIN 17317-3, a new high-affinity probe for voltage-gated sodium channels. Biochemistry. 38: 11137-46. PMID 10460170 DOI: 10.1021/bi990336p  1
1999 Glossmann H, Petrischor G, Bartsch G. Molecular mechanisms of the effects of sildenafil (VIAGRA). Experimental Gerontology. 34: 305-18. PMID 10433386 DOI: 10.1016/S0531-5565(99)00003-0  1
1999 Braverman N, Lin P, Moebius FF, Obie C, Moser A, Glossmann H, Wilcox WR, Rimoin DL, Smith M, Kratz L, Kelley RI, Valle D. Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nature Genetics. 22: 291-4. PMID 10391219 DOI: 10.1038/10357  1
1999 Fitzky BU, Glossmann H, Utermann G, Moebius FF. Molecular genetics of the Smith-Lemli-Opitz syndrome and postsqualene sterol metabolism. Current Opinion in Lipidology. 10: 123-31. PMID 10327280 DOI: 10.1097/00041433-199904000-00006  1
1999 Berjukow S, Gapp F, Aczél S, Sinnegger MJ, Mitterdorfer J, Glossmann H, Hering S. Sequence differences between alpha1C and alpha1S Ca2+ channel subunits reveal structural determinants of a guarded and modulated benzothiazepine receptor. The Journal of Biological Chemistry. 274: 6154-60. PMID 10037699 DOI: 10.1074/jbc.274.10.6154  1
1999 Moebius FF, Soellner KE, Fiechtner B, Huck CW, Bonn G, Glossmann H. Histidine77, glutamic acid81, glutamic acid123, threonine126, asparagine194, and tryptophan197 of the human emopamil binding protein are required for in vivo sterol delta 8-delta 7 isomerization. Biochemistry. 38: 1119-27. PMID 9894009 DOI: 10.1021/bi981804i  1
1998 Mitterdorfer J, Grabner M, Kraus RL, Hering S, Prinz H, Glossmann H, Striessnig J. Molecular basis of drug interaction with L-type Ca2+ channels. Journal of Bioenergetics and Biomembranes. 30: 319-34. PMID 9758329 DOI: 10.1023/A:1021933504909  1
1998 Moebius FF, Reiter RJ, Bermoser K, Glossmann H, Cho SY, Paik YK. Pharmacological analysis of sterol delta8-delta7 isomerase proteins with [3H]ifenprodil. Molecular Pharmacology. 54: 591-8. PMID 9730919  1
1998 Fitzky BU, Witsch-Baumgartner M, Erdel M, Lee JN, Paik YK, Glossmann H, Utermann G, Moebius FF. Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proceedings of the National Academy of Sciences of the United States of America. 95: 8181-6. PMID 9653161 DOI: 10.1073/pnas.95.14.8181  1
1998 Striessnig J, Grabner M, Mitterdorfer J, Hering S, Sinnegger MJ, Glossmann H. Structural basis of drug binding to L Ca2+ channels. Trends in Pharmacological Sciences. 19: 108-15. PMID 9584627 DOI: 10.1016/S0165-6147(98)01171-7  1
1998 Neuhuber B, Gerster U, Döring F, Glossmann H, Tanabe T, Flucher BE. Association of calcium channel alpha1S and beta1a subunits is required for the targeting of beta1a but not of alpha1S into skeletal muscle triads. Proceedings of the National Academy of Sciences of the United States of America. 95: 5015-20. PMID 9560220 DOI: 10.1073/pnas.95.9.5015  1
1998 Neuhuber B, Gerster U, Mitterdorfer J, Glossmann H, Flucher BE. Differential effects of Ca2+ channel beta1a and beta2a subunits on complex formation with alpha1S and on current expression in tsA201 cells. The Journal of Biological Chemistry. 273: 9110-8. PMID 9535900 DOI: 10.1074/jbc.273.15.9110  1
1998 Kraus RL, Sinnegger MJ, Glossmann H, Hering S, Striessnig J. Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. The Journal of Biological Chemistry. 273: 5586-90. PMID 9488686 DOI: 10.1074/jbc.273.10.5586  1
1998 Moebius FF, Fitzky BU, Lee JN, Paik YK, Glossmann H. Molecular cloning and expression of the human delta7-sterol reductase. Proceedings of the National Academy of Sciences of the United States of America. 95: 1899-902. PMID 9465114 DOI: 10.1073/pnas.95.4.1899  1
1997 Sinnegger MJ, Wang Z, Grabner M, Hering S, Striessnig J, Glossmann H, Mitterdorfer J. Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. The Journal of Biological Chemistry. 272: 27686-93. PMID 9346909 DOI: 10.1074/jbc.272.44.27686  1
1997 Moebius FF, Reiter RJ, Hanner M, Glossmann H. High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase. British Journal of Pharmacology. 121: 1-6. PMID 9146879 DOI: 10.1038/sj.bjp.0701079  1
1997 Moebius FF, Striessnig J, Glossmann H. The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends in Pharmacological Sciences. 18: 67-70. PMID 9133773 DOI: 10.1016/S0165-6147(96)01037-1  1
1997 Brauns T, Prinz H, Kimball SD, Haugland RP, Striessnig J, Glossmann H. L-type calcium channels: binding domains for dihydropyridines and benzothiazepines are located in close proximity to each other. Biochemistry. 36: 3625-31. PMID 9132014 DOI: 10.1021/bi9613584  1
1997 Hinterdorfer P, Gruber HJ, Striessnig J, Glossmann H, Schindler H. Analysis of membrane protein self-association in lipid systems by fluorescence particle counting: application to the dihydropyridine receptor. Biochemistry. 36: 4497-504. PMID 9109657 DOI: 10.1021/bi962009c  1
1997 Glossmann H, Moebius U. Use of unlicensed nitric oxide in Austria. Lancet. 349: 509-10. PMID 9040611  1
1996 Moebius FF, Bermoser K, Reiter RJ, Hanner M, Glossmann H. Yeast sterol C8-C7 isomerase: identification and characterization of a high-affinity binding site for enzyme inhibitors. Biochemistry. 35: 16871-8. PMID 8988026 DOI: 10.1021/bi961996m  1
1996 Mitterdorfer J, Wang Z, Sinnegger MJ, Hering S, Striessnig J, Grabner M, Glossmann H. Two amino acid residues in the IIIS5 segment of L-type calcium channels differentially contribute to 1,4-dihydropyridine sensitivity. The Journal of Biological Chemistry. 271: 30330-5. PMID 8939992 DOI: 10.1074/jbc.271.48.30330  1
1996 Pichler M, Wang Z, Grabner-Weiss C, Reimer D, Hering S, Grabner M, Glossmann H, Striessnig J. Block of P/Q-type calcium channels by therapeutic concentrations of aminoglycoside antibiotics. Biochemistry. 35: 14659-64. PMID 8931565 DOI: 10.1021/bi961657t  1
1996 Hering S, Aczél S, Grabner M, Döring F, Berjukow S, Mitterdorfer J, Sinnegger MJ, Striessnig J, Degtiar VE, Wang Z, Glossmann H. Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels. The Journal of Biological Chemistry. 271: 24471-5. PMID 8798706 DOI: 10.1074/jbc.271.40.24471  1
1996 Berjukow S, Döring F, Froschmayr M, Grabner M, Glossmann H, Hering S. Endogenous calcium channels in human embryonic kidney (HEK293) cells. British Journal of Pharmacology. 118: 748-54. PMID 8762103  1
1996 Mitterdorfer J, Froschmayr M, Grabner M, Moebius FF, Glossmann H, Striessnig J. Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry. 35: 9400-6. PMID 8755718 DOI: 10.1021/bi960683o  1
1996 Hanner M, Moebius FF, Flandorfer A, Knaus HG, Striessnig J, Kempner E, Glossmann H. Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proceedings of the National Academy of Sciences of the United States of America. 93: 8072-7. PMID 8755605 DOI: 10.1073/pnas.93.15.8072  1
1996 Döring F, Degtiar VE, Grabner M, Striessnig J, Hering S, Glossman H. Transfer of L-type calcium channel IVS6 segment increases phenylalkylamine sensitivity of alpha1A. The Journal of Biological Chemistry. 271: 11745-9. PMID 8662622  1
1996 Boer R, Dichtl M, Borchers C, Ulrich WR, Marecek JF, Prestwich GD, Glossmann H, Striessnig J. Reversible labeling of a chemosensitizer binding domain of p-glycoprotein with a novel 1,4-dihydropyridine drug transport inhibitor. Biochemistry. 35: 1387-96. PMID 8634268 DOI: 10.1021/bi951912u  1
1996 Grabner M, Wang Z, Hering S, Striessnig J, Glossmann H. Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron. 16: 207-18. PMID 8562085 DOI: 10.1016/S0896-6273(00)80037-9  1
1996 Knaus HG, Schwarzer C, Koch RO, Eberhart A, Kaczorowski GJ, Glossmann H, Wunder F, Pongs O, Garcia ML, Sperk G. Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 16: 955-63. PMID 8558264  1
1995 Hofmann J, Gekeler V, Ise W, Noller A, Mitterdorfer J, Hofer S, Utz I, Gotwald M, Boer R, Glossmann H. Mechanism of action of dexniguldipine-HCl (B8509-035), a new potent modulator of multidrug resistance. Biochemical Pharmacology. 49: 603-9. PMID 7887974 DOI: 10.1016/0006-2952(94)00479-6  1
1995 Brauns T, Cai ZW, Kimball SD, Kang KC, Haugland RP, Berger W, Berjukov S, Hering S, Glossmann H, Striessnig J. Benzothiazepine binding domain of purified L-type calcium channels: direct labeling using a novel fluorescent diltiazem analogue. Biochemistry. 34: 3461-9. PMID 7880840  1
1995 Kwan YW, Bangalore R, Lakitsh M, Glossmann H, Kass RS. Inhibition of cardiac L-type calcium channels by quaternary amlodipine: implications for pharmacokinetics and access to dihydropyridine binding site. Journal of Molecular and Cellular Cardiology. 27: 253-62. PMID 7760349  1
1995 Hanner M, Moebius FF, Weber F, Grabner M, Striessnig J, Glossmann H. Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. The Journal of Biological Chemistry. 270: 7551-7. PMID 7706302  1
1995 Mitterdorfer J, Sinnegger MJ, Grabner M, Striessnig J, Glossmann H. Coordination of Ca2+ by the pore region glutamates is essential for high-affinity dihydropyridine binding to the cardiac Ca2+ channel alpha 1 subunit. Biochemistry. 34: 9350-5. PMID 7626604  1
1995 Wang Z, Grabner M, Berjukow S, Savchenko A, Glossmann H, Hering S. Chimeric L-type Ca2+ channels expressed in Xenopus laevis oocytes reveal role of repeats III and IV in activation gating. The Journal of Physiology. 486: 131-7. PMID 7562629  1
1995 Savchenko A, Glossmann H, Hering S. Improved micro-perfusion chamber for multiple and rapid solution exchange in adherent single cells. PflüGers Archiv : European Journal of Physiology. 429: 436-42. PMID 7539128 DOI: 10.1007/BF00374161  1
1994 Grabner M, Bachmann A, Rosenthal F, Striessnig J, Schultz C, Tautz D, Glossmann H. Insect calcium channels. Molecular cloning of an alpha 1-subunit from housefly (Musca domestica) muscle. Febs Letters. 339: 189-94. PMID 8313972 DOI: 10.1016/0014-5793(94)80413-3  1
1994 Grabner M, Wang Z, Mitterdorfer J, Rosenthal F, Charnet P, Savchenko A, Hering S, Ren D, Hall LM, Glossmann H. Cloning and functional expression of a neuronal calcium channel beta subunit from house fly (Musca domestica). The Journal of Biological Chemistry. 269: 23668-74. PMID 8089136  1
1994 Moebius FF, Hanner M, Knaus HG, Weber F, Striessnig J, Glossmann H. Purification and amino-terminal sequencing of the high affinity phenylalkylamine Ca2+ antagonist binding protein from guinea pig liver endoplasmic reticulum. The Journal of Biological Chemistry. 269: 29314-20. PMID 7961902  1
1994 Mitterdorfer J, Froschmayr M, Grabner M, Striessnig J, Glossmann H. Calcium channels: the beta-subunit increases the affinity of dihydropyridine and Ca2+ binding sites of the alpha 1-subunit. Febs Letters. 352: 141-5. PMID 7925963 DOI: 10.1016/0014-5793(94)00938-4  1
1994 Berger W, Prinz H, Striessnig J, Kang HC, Haugland R, Glossmann H. Complex molecular mechanism for dihydropyridine binding to L-type Ca(2+)-channels as revealed by fluorescence resonance energy transfer. Biochemistry. 33: 11875-83. PMID 7918406  1
1994 Knaus HG, Eberhart A, Glossmann H, Munujos P, Kaczorowski GJ, Garcia ML. Pharmacology and structure of high conductance calcium-activated potassium channels. Cellular Signalling. 6: 861-70. PMID 7718406 DOI: 10.1016/0898-6568(94)90019-1  1
1993 Moebius FF, Burrows GG, Striessnig J, Glossmann H. Biochemical characterization of a 22-kDa high affinity antiischemic drug-binding polypeptide in the endoplasmic reticulum of guinea pig liver: potential common target for antiischemic drug action. Molecular Pharmacology. 43: 139-48. PMID 8429820  1
1993 Glossmann H, Hering S, Savchenko A, Berger W, Friedrich K, Garcia ML, Goetz MA, Liesch JM, Zink DL, Kaczorowski GJ. A light stabilizer (Tinuvin 770) that elutes from polypropylene plastic tubes is a potent L-type Ca(2+)-channel blocker. Proceedings of the National Academy of Sciences of the United States of America. 90: 9523-7. PMID 8415734  1
1993 Lakitsch M, Knaus HG, Topar G, Romanin C, Boer R, Flockerzi D, Striessnig J, Schindler H, Hoeltje HD, Glossmann H. Heterogeneity of L-type calcium channel alpha 1 subunits: stereoselective discrimination of different populations by the novel 1,4-dihydropyridine B 874-67. Molecular Pharmacology. 43: 293-301. PMID 8381514  1
1993 Moebius FF, Burrows GG, Hanner M, Schmid E, Striessnig J, Glossmann H. Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. Molecular Pharmacology. 44: 966-71. PMID 8246920  1
1993 Strübing C, Hering S, Glossmann H. Evidence for an external location of the dihydropyridine agonist receptor site on smooth muscle and skeletal muscle calcium channels. British Journal of Pharmacology. 108: 884-91. PMID 7683566  1
1993 Striessnig J, Berger W, Glossmann H. Molecular properties of voltage-dependent ca2+ channels in excitable tissues Cellular Physiology and Biochemistry. 3: 295-317. DOI: 10.1159/000154695  1
1992 Romanin C, Seydl K, Glossmann H, Schindler H. The dihydropyridine niguldipine inhibits T-type Ca2+ currents in atrial myocytes. PflüGers Archiv : European Journal of Physiology. 420: 410-2. PMID 1598197 DOI: 10.1007/BF00374478  1
1992 Knaus HG, Moshammer T, Friedrich K, Kang HC, Haugland RP, Glossmann H. In vivo labeling of L-type Ca2+ channels by fluorescent dihydropyridines: Evidence for a functional, extracellular heparin-binding site Proceedings of the National Academy of Sciences of the United States of America. 89: 3586-3590. PMID 1314393  1
1992 Knaus HG, Striessnig J, Hering S, Marrer S, Schwenner E, Höltje HD, Glossmann H. [35S]sadopine, a novel high affinity, high specific activity, L-type Ca2+ channel probe: characterization of two equipotent diastereomers with opposite allosteric properties. Molecular Pharmacology. 41: 298-307. PMID 1311409  1
1992 Knaus HG, Moshammer T, Kang HC, Haugland RP, Glossmann H. A unique fluorescent phenylalkylamine probe for L-type Ca2+ channels. Coupling of phenylalkylamine receptors to Ca2+ and dihydropyridine binding sites. The Journal of Biological Chemistry. 267: 2179-89. PMID 1310311  1
1991 Glossmann H, Zech C, Striessnig J, Staudinger R, Hall L, Greenberg R, Armah BI. Very high affinity interaction of DPI 201-106 and BDF 8784 enantiomers with the phenylalkylamine-sensitive Ca2(+)-channel in Drosophila head membranes. British Journal of Pharmacology. 102: 446-52. PMID 1849770  1
1991 Grabner M, Friedrich K, Knaus HG, Striessnig J, Scheffauer F, Staudinger R, Koch WJ, Schwartz A, Glossmann H. Calcium channels from Cyprinus carpio skeletal muscle. Proceedings of the National Academy of Sciences of the United States of America. 88: 727-31. PMID 1846962  1
1991 Zech C, Staudinger R, Mühlbacher J, Glossmann H. Novel sites for phenylalkylamines: characterisation of a sodium-sensitive drug receptor with (-)-[3H]emopamil. European Journal of Pharmacology. 208: 119-30. PMID 1800125 DOI: 10.1016/0922-4106(91)90062-M  1
1991 Himmel HM, Glossmann H, Ravens U. Naftopidil, a new alpha-adrenoceptor blocking agent with calcium antagonistic properties: characterization of Ca2+ antagonistic effects. Journal of Cardiovascular Pharmacology. 17: 213-21. PMID 1709225  1
1991 Wöll E, Paulmichl M, Lang F, Glossmann H. Effect of alpha-adrenoceptor agonists on cell membrane potential in renal epitheloid Madin Darby canine kidney cells. European Journal of Pharmacology. 195: 399-401. PMID 1678352 DOI: 10.1016/0014-2999(91)90482-6  1
1991 Nakayama H, Taki M, Striessnig J, Glossmann H, Catterall WA, Kanaoka Y. Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine. Proceedings of the National Academy of Sciences of the United States of America. 88: 9203-7. PMID 1656465  1
1991 Haase H, Striessnig J, Holtzhauer M, Vetter R, Glossmann H. A rapid procedure for the purification of cardiac 1,4-dihydropyridine receptors from porcine heart. European Journal of Pharmacology. 207: 51-9. PMID 1655494 DOI: 10.1016/S0922-4106(05)80037-9  1
1991 Staudinger R, Knaus HG, Glossmann H. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140. The Journal of Biological Chemistry. 266: 10787-95. PMID 1645709  1
1990 Striessnig J, Glossmann H, Catterall WA. Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels. Proceedings of the National Academy of Sciences of the United States of America. 87: 9108-12. PMID 2174553  1
1990 Knaus HG, Scheffauer F, Romanin C, Schindler HG, Glossmann H. Heparin binds with high affinity to voltage-dependent L-type Ca2+ channels. Evidence for an agonistic action. The Journal of Biological Chemistry. 265: 11156-66. PMID 2162834  1
1990 Glossmann H, Striessnig J. Molecular properties of calcium channels. Reviews of Physiology, Biochemistry and Pharmacology. 114: 1-105. PMID 2155469  1
1990 Striessnig J, Scheffauer F, Mitterdorfer J, Schirmer M, Glossmann H. Identification of the benzothiazepine-binding polypeptide of skeletal muscle calcium channels with (+)-cis-azidodiltiazem and anti-ligand antibodies. The Journal of Biological Chemistry. 265: 363-70. PMID 2152924  1
1990 Lechleitner P, Dzien A, Haring C, Glossmann H. Uneventful self poisoning with a very high dose of captopril. Toxicology. 64: 325-9. PMID 2148447 DOI: 10.1016/0300-483X(90)90124-Y  1
1990 Glossmann H. New therapeutic uses of calcium channel blockers. Introduction. Journal of Neural Transmission. Supplementum. 31: 1-3. PMID 2074435  1
1990 Zernig G, Graziadei I, Moshammer T, Zech C, Reider N, Glossmann H. Mitochondrial Ca2+ antagonist binding sites are associated with an inner mitochondrial membrane anion channel. Molecular Pharmacology. 38: 362-9. PMID 1698252  1
1989 Grassegger A, Striessnig J, Weiler M, Knaus HG, Glossmann H. [3H]HOE166 defines a novel calcium antagonist drug receptor--distinct from the 1,4 dihydropyridine binding domain. Naunyn-Schmiedeberg's Archives of Pharmacology. 340: 752-9. PMID 2561307 DOI: 10.1007/BF00169685  1
1989 Graziadei I, Zernig G, Grassegger A, Boer R, Schudt C, Glossmann H. Hydrophobic calcium channel ligands: methodical problems and their solution. The American Journal of Cardiology. 64: 43I-50I. PMID 2554713 DOI: 10.1016/0002-9149(89)90959-4  1
1989 Boer R, Grassegger A, Schudt C, Glossmann H. (+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors. European Journal of Pharmacology. 172: 131-45. PMID 2548881 DOI: 10.1016/0922-4106(89)90004-7  1
1989 Glossmann H, Striessnig J, Knaus HG, Müller J, Grassegger A, Höltje HD, Marrer S, Hymel L, Schindler HG. Structure of calcium channels. Annals of the New York Academy of Sciences. 560: 198-214. PMID 2545133  1
1989 Greenberg RM, Striessnig J, Koza A, Devay P, Glossmann H, Hall LM. Native and detergent-solubilized membrane extracts from Drosophila heads contain binding sites for phenylalkylamine calcium channel blockers Insect Biochemistry. 19: 309-322. DOI: 10.1016/0020-1790(89)90077-2  1
1989 Hymel L, Schindler H, Inui M, Fleischer S, Striessnig J, Glossmann H. A molecular model of excitation - contraction coupling at the skeletal muscle triad junction via coassociated oligomeric calcium channels Annals of the New York Academy of Sciences. 560: 185-188.  1
1988 Zernig G, Glossmann H. A novel 1,4-dihydropyridine-binding site on mitochondrial membranes from guinea-pig heart, liver and kidney. The Biochemical Journal. 253: 49-58. PMID 3421952  1
1988 Glossmann H, Striessnig J. Calcium channels. Vitamins and Hormones. 44: 155-328. PMID 2853487  1
1988 Zernig G, Moshammer T, Graziadei I, Glossmann H. The mitochondrial high-capacity low-affinity (+/-)-[3H]nitrendipine binding site is regulated by nucleotides. European Journal of Pharmacology. 157: 67-73. PMID 2853075 DOI: 10.1016/0014-2999(88)90472-4  1
1988 Ferry D, Armah BI, Goll A, Glossmann H. Characteristics of the binding of the antihypertensive agent moxonidine to alpha 2-adrenoceptors in rat brain membranes. Arzneimittel-Forschung. 38: 1442-5. PMID 2848534  1
1988 Striessnig J, Knaus HG, Glossmann H. Photoaffinity-labelling of the calcium-channel-associated 1,4-dihydropyridine and phenylalkylamine receptor in guinea-pig hippocampus. A 195 kDa polypeptide carries both drug receptors and has similarities to the alpha 1 subunit of the purified skeletal-muscle calcium channel. The Biochemical Journal. 253: 39-47. PMID 2844171  1
1988 Striessnig J, Meusburger E, Grabner M, Knaus HG, Glossmann H, Kaiser J, Schölkens B, Becker R, Linz W, Henning R. Evidence for a distinct Ca2+ antagonist receptor for the novel benzothiazinone compound HOE 166. Naunyn-Schmiedeberg's Archives of Pharmacology. 337: 331-40. PMID 2839780 DOI: 10.1007/BF00168847  1
1988 Hymel L, Striessnig J, Glossmann H, Schindler H. Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers. Proceedings of the National Academy of Sciences of the United States of America. 85: 4290-4. PMID 2454467  1
1988 Glossmann H, Striessnig J, Hymel L, Schindler H. Purification and reconstitution of calcium channel drug-receptor sites. Annals of the New York Academy of Sciences. 522: 150-61. PMID 2454049  1
1988 Zernig G, Moshammer T, Glossmann H. Phosphatidylinositol turnover as a functional probe for neuronal Ca2+ channels. Progress in Clinical and Biological Research. 252: 41-5. PMID 2450375  1
1988 Striessnig J, Glossmann H. Characterization of the drug receptors of the purified skeletal muscle calcium channel. Progress in Clinical and Biological Research. 252: 35-40. PMID 2450374  1
1988 Glossmann H, Striessnig J. Structure and pharmacology of voltage-dependent calcium channels Isi Atlas of Science: Pharmacology. 2: 202-210.  1
1988 Ferry DR, Goll A, Glossmann H, Glaser T, Traber J. Radiation inactivation of 5-HT receptor subtypes in calf brain Neuroscience Research Communications. 2: 9-17.  1
1987 Knaus HG, Striessnig J, Koza A, Glossmann H. Neurotoxic aminoglycoside antibiotics are potent inhibitors of [125I]-Omega-Conotoxin GVIA binding to guinea-pig cerebral cortex membranes. Naunyn-Schmiedeberg's Archives of Pharmacology. 336: 583-6. PMID 2830547 DOI: 10.1007/BF00169318  1
1987 Glossmann H, Striessnig J, Hymel L, Schindler H. Purified L-type calcium channels: only one single polypeptide (alpha 1-subunit) carries the drug receptor domains and is regulated by protein kinases. Biomedica Biochimica Acta. 46: S351-6. PMID 2449181  1
1987 Vaghy PL, Striessnig J, Miwa K, Knaus HG, Itagaki K, McKenna E, Glossmann H, Schwartz A. Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. The Journal of Biological Chemistry. 262: 14337-42. PMID 2443504  1
1987 Glossmann H, Striessnig J, Ferry DR, Goll A, Moosburger K, Schirmer M. Interaction between calcium channel ligands and calcium channels. Circulation Research. 61: I30-6. PMID 2443273  1
1987 Ferry DR, Goll A, Glossmann H. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand. The Biochemical Journal. 243: 127-35. PMID 2440422  1
1987 Striessnig J, Knaus HG, Grabner M, Moosburger K, Seitz W, Lietz H, Glossmann H. Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. Febs Letters. 212: 247-53. PMID 2434359 DOI: 10.1016/0014-5793(87)81354-6  1
1987 Glossmann H, Ferry DR, Striessnig J, Goll A, Moosburger K. Resolving the structure of the Ca2+ channel by photoaffinity labelling Trends in Pharmacological Sciences. 8: 95-100. DOI: 10.1016/0165-6147(87)90082-4  1
1986 Zernig G, Moshammer T, Glossmann H. Stereospecific regulation of [3H]inositol monophosphate accumulation by calcium channel drugs from all three main chemical classes. European Journal of Pharmacology. 128: 221-9. PMID 3098571 DOI: 10.1016/0014-2999(86)90769-7  1
1986 Goll A, Glossmann H, Mannhold R. Correlation between the negative inotropic potency and binding parameters of 1,4-dihydropyridine and phenylalkylamine calcium channel blockers in cat heart. Naunyn-Schmiedeberg's Archives of Pharmacology. 334: 303-12. PMID 3027587 DOI: 10.1007/BF00508786  1
1986 Striessnig J, Moosburger K, Goll A, Ferry DR, Glossmann H. Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel. European Journal of Biochemistry / Febs. 161: 603-9. PMID 2431906 DOI: 10.1111/j.1432-1033.1986.tb10484.x  1
1986 Seagar MJ, Labbé-Jullié C, Granier C, Goll A, Glossmann H, Van Rietschoten J, Couraud F. Molecular structure of rat brain apamin receptor: differential photoaffinity labeling of putative K+ channel subunits and target size analysis. Biochemistry. 25: 4051-7. PMID 2427110  1
1986 Striessnig J, Goll A, Moosburger K, Glossmann H. Purified calcium channels have three allosterically coupled drug receptors. Febs Letters. 197: 204-10. PMID 2419161 DOI: 10.1016/0014-5793(86)80327-1  1
1985 Striessnig J, Zernig G, Glossmann H. Human red-blood-cell Ca2+-antagonist binding sites. Evidence for an unusual receptor coupled to the nucleoside transporter. European Journal of Biochemistry / Febs. 150: 67-77. PMID 2990927  1
1985 Glossmann H, Baukal A, Aguilera G, Catt KJ. Radioligand assay for angiotensin II receptors. Methods in Enzymology. 109: 110-26. PMID 2985913  1
1985 Striessnig J, Zernig G, Glossmann H. Ca2+ antagonist receptor sites on human red blood cell membranes. European Journal of Pharmacology. 108: 329-30. PMID 2985404 DOI: 10.1016/0014-2999(85)90460-1  1
1985 Glossmann H, Ferry DR. Assay for calcium channels. Methods in Enzymology. 109: 513-50. PMID 2581112  1
1985 Glossmann H, Ferry DR, Goll A, Linn T. Molecular approach to the calcium channel. Advances in Myocardiology. 5: 41-76. PMID 2578683  1
1985 Glossmann H. Activation of chromaffin cell Ca2+ channels by novel dihydropyridine. Nature. 313: 503-4. PMID 2578625 DOI: 10.1038/313503c0  1
1985 Glossmann H, Ferry DR, Goll A, Striessnig J, Zernig G. Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneimittel-Forschung. 35: 1917-35. PMID 2420337  1
1985 Ferry DR, Kämpf K, Goll A, Glossmann H. Subunit composition of skeletal muscle transverse tubule calcium channels evaluated with the 1,4-dihydropyridine photoaffinity probe, [3H]azidopine. The Embo Journal. 4: 1933-40. PMID 2415355  1
1985 Glossmann H, Ferry DR, Goll A, Striessnig J, Schober M. Calcium channels: basic properties as revealed by radioligand binding studies. Journal of Cardiovascular Pharmacology. 7: S20-30. PMID 2414589  1
1985 Ferry DR, Goll A, Rombusch M, Glossmann H. The molecular pharmacology and structural features of calcium channels. British Journal of Clinical Pharmacology. 20: 233S-246S. PMID 2413875 DOI: 10.1111/j.1365-2125.1985.tb02809.x  1
1985 Ferry DR, Glossmann H, Kaumann AJ. Relationship between the stereoselective negative inotropic effects of verapamil enantiomers and their binding to putative calcium channels in human heart. British Journal of Pharmacology. 84: 811-24. PMID 2408698  1
1984 Goll A, Ferry DR, Glossmann H. Target size analysis and molecular properties of Ca2+ channels labelled with [3H]verapamil. European Journal of Biochemistry / Febs. 141: 177-86. PMID 6327306  1
1984 Ferry DR, Glossmann H. 125I-iodipine, a new high affinity ligand for the putative calcium channel. Naunyn-Schmiedeberg's Archives of Pharmacology. 325: 186-9. PMID 6325952 DOI: 10.1007/BF00506200  1
1984 Ferry DR, Rombush M, Goll A, Glossmann H. Photoaffinity labelling of Ca2+ channels with [3H]azidopine. Febs Letters. 169: 112-8. PMID 6325234 DOI: 10.1016/0014-5793(84)80299-9  1
1984 Albus U, Habermann E, Ferry DR, Glossmann H. Novel 1,4-dihydropyridine (Bay K 8644) facilitates calcium-dependent [3H]noradrenaline release from PC 12 cells. Journal of Neurochemistry. 42: 1186-9. PMID 6199462  1
1984 Glossmann H, Goll A, Ferry DR, Rombusch M. The identification of cytoplasmic membrane calcium-entry channels by ligand-binding studies. Biochemical Society Transactions. 12: 941-3. PMID 6099291  1
1984 Ferry DR, Goll A, Gadow C, Glossmann H. (-)-3H-desmethoxyverapamil labelling of putative calcium channels in brain: autoradiographic distribution and allosteric coupling to 1,4-dihydropyridine and diltiazem binding sites. Naunyn-Schmiedeberg's Archives of Pharmacology. 327: 183-7. PMID 6092974 DOI: 10.1007/BF00500915  1
1984 Goll A, Ferry DR, Striessnig J, Schober M, Glossmann H. (-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. Febs Letters. 176: 371-7. PMID 6092142 DOI: 10.1016/0014-5793(84)81199-0  1
1984 Glossmann H, Ferry DR, Goll A, Rombusch M. Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [125I]iodipine. Journal of Cardiovascular Pharmacology. 6: S608-21. PMID 6083403  1
1983 Ferry DR, Goll A, Glossmann H. Calcium channels: evidence for oligomeric nature by target size analysis. The Embo Journal. 2: 1729-32. PMID 6315398  1
1983 Ferry DR, Goll A, Glossmann H. Putative calcium channel molecular weight determination by target size analysis. Naunyn-Schmiedeberg's Archives of Pharmacology. 323: 292-7. PMID 6314150 DOI: 10.1007/BF00512466  1
1983 Glossmann H, Ferry DR. Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine. Naunyn-Schmiedeberg's Archives of Pharmacology. 323: 279-91. PMID 6314149 DOI: 10.1007/BF00512465  1
1983 Ferry DR, Goll A, Glossmann H. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110. Naunyn-Schmiedeberg's Archives of Pharmacology. 323: 276-7. PMID 6312337 DOI: 10.1007/BF00497674  1
1983 Lübbecke F, Ferry DR, Glossmann H, Sattler EL, Doell G. Radiation inactivation of alpha 1-adrenoceptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 323: 96-100. PMID 6310418 DOI: 10.1007/BF00634255  1
1983 Glossmann H, Linn T, Rombusch M, Ferry DR. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists. Febs Letters. 160: 226-32. PMID 6309565 DOI: 10.1016/0014-5793(83)80972-7  1
1983 Glossmann H, Ferry DR, Boschek CB. Purification of the putative calcium channel from skeletal muscle with the aid of [3H]-nimodipine binding. Naunyn-Schmiedeberg's Archives of Pharmacology. 323: 1-11. PMID 6308477 DOI: 10.1007/BF00498821  1
1983 Goll A, Ferry DR, Glossmann H. Target size analysis of skeletal muscle Ca2+ channels. Positive allosteric heterotropic regulation by d-cis-diltiazem is associated with apparent channel oligomer dissociation. Febs Letters. 157: 63-9. PMID 6305718 DOI: 10.1016/0014-5793(83)81117-X  1
1983 Glossmann H, Ferry DR, Lübbecke F, Mewes R, Hofmann F. Identification of voltage operated calcium channels by binding studies: differentiation of subclasses of calcium antagonist drugs with 3H-nimodipine radioligand binding. Journal of Receptor Research. 3: 177-90. PMID 6304295 DOI: 10.3109/10799898309041932  1
1983 Ferry DR, Glossmann H. Tissue specific regulation of (3H) nimodipine binding to putative calcium channels by the biologically active isomer of diltiazem British Journal of Pharmacology. 78.  1
1982 Bellemann P, Ferry D, Lübbecke F, Glossmann H. [3H]-Nimodipine and [3H]-nitrendipine as tools to directly identify the sites of action of 1,4-dihydropyridine calcium antagonists in guinea-pig tissues. Tissue-specific effects of anions and ionic strength. Arzneimittel-Forschung. 32: 361-3. PMID 7201804  1
1982 Bellemann P, Ferry D, Luebbecke F, Glossmann H. [3H]-nitrendipine, a potent calcium antagonist, binds with high affinity to cardiac membranes Arzneimittel-Forschung/Drug Research. 31: 2064-2067. PMID 7199299  1
1982 Ferry DR, Glossmann H. Identification of putative calcium channels in skeletal muscle microsomes. Febs Letters. 148: 331-7. PMID 6295810 DOI: 10.1016/0014-5793(82)80835-1  1
1982 Schwabe U, Lenschow V, Ukena D, Ferry DR, Glossmann H. [125I] N6-p-Hydroxyphenylisopropyladenosine, a new ligand for Ri adenosine receptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 321: 84-7. PMID 6292745 DOI: 10.1007/BF00586356  1
1982 Ferry DR, Glossmann H. Evidence of multiple receptor sites within the putative calcium channel. Naunyn-Schmiedeberg's Archives of Pharmacology. 321: 80-3. PMID 6292744 DOI: 10.1007/BF00586355  1
1982 Glossmann H, Lübbecke F. [125I]-HEAT:fifty percent of the ligand can bind to the alpha1-adrenoceptors with extremely high affinity. Naunyn-Schmiedeberg's Archives of Pharmacology. 321: 7-10. PMID 6292742 DOI: 10.1007/BF00586341  1
1982 Howard RF, Friis RR, Sheppard JR, Glossmann H. The increase in hormone-stimulated adenylate cyclase activity following Rous sarcoma virus transformation. Journal of Cellular Physiology. 111: 295-302. PMID 6284770 DOI: 10.1002/jcp.1041110311  1
1982 Glossmann H, Lübbecke F, Bellemann P, Sattler EL, Doell G. Ionic modulation of alpha-adrenoceptors. Journal of Cardiovascular Pharmacology. 4: S51-7. PMID 6175845  1
1982 Glossmann H, Ferry DR, Lübbecke F, Mewes R, Hofmann F. Calcium channels: direct identification with radioligand binding studies Trends in Pharmacological Sciences. 3: 431-437. DOI: 10.1016/0165-6147(82)91221-4  1
1981 Glossmann H, Lübbecke F, Bellemann P. [125I]-HEAT, a selective, high-affinity, high specific activity ligand for alpha 1-adrenoceptors. Naunyn-Schmiedeberg's Archives of Pharmacology. 318: 1-9. PMID 6276785 DOI: 10.1007/BF00503304  1
1981 Bonacker O, Glossmann H. Mammalian beta-adrenoceptors: concomitant biospecific elution with protein kinase activity from Sepharose-alprenolol. European Journal of Pharmacology. 75: 197-204. PMID 6274666 DOI: 10.1016/0014-2999(81)90545-8  1
1981 Glossmann H, Presek P, Eigenbrodt E. Quercetin inhibits tyrosine phosphorylation by the cyclic nucleotide-independent, transforming protein kinase, pp60src. Naunyn-Schmiedeberg's Archives of Pharmacology. 317: 100-2. PMID 6269001 DOI: 10.1007/BF00506266  1
1981 Glossmann H, Presek P, Eigenbrodt E. Association of the src-gene product of Rous sarcoma virus with a pyruvate-kinase inactivation factor. Molecular and Cellular Endocrinology. 23: 49-63. PMID 6167476 DOI: 10.1016/0303-7207(81)90116-7  1
1981 Glossmann H, Lübbecke F, Bellemann P, Presek P. Cation sensitivity of [125I]heat binding to alpha 1-adrenoceptors in rat cerebral cortex membranes. European Journal of Pharmacology. 75: 149-53. PMID 6119216 DOI: 10.1016/0014-2999(81)90076-5  1
1981 Bonacker O, Glossmann H. Purification of the mammalian β-adrenoceptor Naunyn-Schmiedeberg's Archives of Pharmacology. 316: 230.  1
1980 Glossmann H, Hornung R. Alpha 2 adrenoceptors in rat brain: the divalent cation site. Naunyn-Schmiedeberg's Archives of Pharmacology. 314: 101-9. PMID 6256664 DOI: 10.1007/BF00504525  1
1980 Glossmann H, Hornung R. Calcium- and potassium-channel blockers interact with alpha-adrenoceptors. Molecular and Cellular Endocrinology. 19: 243-51. PMID 6250930 DOI: 10.1016/0303-7207(80)90054-4  1
1980 Glossmann H, Hornung R, Schlusche R. Sodium ions increase the affinity of clonidine for α1-adrenoceptors in rat brain Naunyn-Schmiedeberg's Archives of Pharmacology. 312: 105-106. PMID 6250084 DOI: 10.1007/BF00569717  1
1980 Glossmann H, Hornung R. alpha-Adrenoceptors in rat brain: sodium changes the affinity of agonists for prazosin sites. European Journal of Pharmacology. 61: 407-8. PMID 6245895 DOI: 10.1016/0014-2999(80)90083-7  1
1980 Presek P, Glossmann H, Eigenbrodt E, Schoner W, Rübsamen H, Friis RR, Bauer H. Similarities between a phosphoprotein (pp60src)-associated protein kinase of Rous sarcoma virus and a cyclic adenosine 3':5'-monophosphate-independent protein kinase that phosphorylates pyruvate kinase type M2. Cancer Research. 40: 1733-41. PMID 6245802  1
1980 Eigenbrodt E, Glossmann H. Glycolysis-one of the keys to cancer? Trends in Pharmacological Sciences. 1: 240-245. DOI: 10.1016/0165-6147(80)90009-7  1
1980 Glossmann H, Hornung R, Presek P. The use of ligand binding for the characterisation of α-adrenoceptors Journal of Cardiovascular Pharmacology. 2: S303-S324.  1
1980 Howard RF, Friis RR, Glossmann H, Sheppard JR. Modulation of hormone-responsive adenylate cyclase activity by Rous sarcoma virus transformation European Journal of Cell Biology. 22: P1556.  1
1979 Ahnert G, Glossmann H, Habermann E. Effects of ion channel toxins and specific neurotoxins on the cyclic nucleotide content of cerebellar slices, primary brain cultures and neural cell lines. Naunyn-Schmiedeberg's Archives of Pharmacology. 307: 151-7. PMID 225686 DOI: 10.1007/BF00498457  1
1979 Hornung R, Presek P, Glossmann H. Alpha adrenoceptors in rat brain: direct identification with prazosin. Naunyn-Schmiedeberg's Archives of Pharmacology. 308: 223-30. PMID 41192 DOI: 10.1007/BF00501386  1
1979 Ahnert G, Glossmann H, Habermann E. Investigations on the mechanism of cyclic guanosine monophosphate increase due to depolarizing agents as studied with sea anemone toxin II in mouse cerebellar slices. Naunyn-Schmiedeberg's Archives of Pharmacology. 307: 159-66. PMID 39260 DOI: 10.1007/BF00498458  1
1978 Kleinstein J, Glossmann H, Braun L, Konrad C. Solubilization of a mammalian beta-adrenergic receptor. Naunyn-Schmiedeberg's Archives of Pharmacology. 305: 191-200. PMID 216931 DOI: 10.1007/BF00498810  1
1978 Struck CJ, Glossmann H. Soluble bovine adrenal cortex guanylate cyclase: effect of sodium nitroprusside, nitrosamines, and hydrophobic ligands on activity, substrate specificity and cation requirement. Naunyn-Schmiedeberg's Archives of Pharmacology. 304: 51-61. PMID 29234 DOI: 10.1007/BF00501377  1
1977 Glossmann H, Struck CJ. Adrenal cortex adenylate cyclase. In vitro modification of the enzyme by cholera toxin. Naunyn-Schmiedeberg's Archives of Pharmacology. 299: 175-85. PMID 198684 DOI: 10.1007/BF00498560  1
1977 Struck CJ, Ahnert G, Glossmann H, Schaeg W. Solid phase radioimmunoassay for cyclic AMP using staphylococcal protein A-antibody adsorbent. Naunyn-Schmiedeberg's Archives of Pharmacology. 298: 67-73. PMID 196225 DOI: 10.1007/BF00510989  1
1977 Scholkens BA, Glossmann H. 1.8 Disubstituted angiotensin II analogues: antagonistic activity in vivo in comparison to their competitive binding activity in a radioligand receptor assay Acta Endocrinologica. 85: No. 317.  1
1976 Glossmann H, Struck CJ. Adrenal cortex adenylate cyclase. In vitro acitivity of ACTH fragments and analogues. Naunyn-Schmiedeberg's Archives of Pharmacology. 294: 199-206. PMID 189224 DOI: 10.1007/BF00507854  1
1976 Glossmann H, Gips H. Adrenal cortex adenylate cyclase. Is Ca2+ involved in ACTH stimulation? Naunyn-Schmiedeberg's Archives of Pharmacology. 292: 199-203. PMID 181684  1
1976 Krawietz W, Poppert D, Erdmann E, Glossmann H, Struck CJ, Konrad C. Beta-adrenergic receptors in guinea-pig myocardial tissue. Naunyn-Schmiedeberg's Archives of Pharmacology. 295: 215-24. PMID 13314 DOI: 10.1007/BF00505089  1
1976 Glossmann H, Gips H. Adrenal cortex adenylate cyclase - Is Ca2+ involved in ACTH stimulation? Naunyn-Schmiedeberg's Archives of Pharmacology. 292: 199-203. DOI: 10.1007/BF00498593  1
1975 Glossmann H. Adrenal cortex adenylate cyclase. Specific binding sites for 5'-guanylyl-imidodiphosphate in partially purified plasma membranes from bovine adrenal cortex. Naunyn-Schmiedeberg's Archives of Pharmacology. 289: 99-109. PMID 1186917  1
1975 Glossmann H. Proceedings: Regulatory nucleotide binding sites for adrenal cortex adenylate cyclase. Naunyn-Schmiedeberg's Archives of Pharmacology. 287: R49. PMID 1143447  1
1975 Glossmann H. Adrenal cortex adenylate cyclase. Solubilization of adenylate cyclase and guanyl nucleotide binding sites Naunyn.Schmied.Arch.Pharm.. 291: 89-100. PMID 172809  1
1975 Glossmann H, Gips H. Bovine adrenal cortex adenylate cyclase: properties of the particulate enzyme and effects of guanyl nucleotides. Naunyn-Schmiedeberg's Archives of Pharmacology. 289: 77-97. PMID 171590 DOI: 10.1007/BF00498031  1
1975 Glossmann H. Adrenal cortex adenylate cyclase - Solubilization of adenylate cyclase and guanyl nucleotide binding sites Naunyn-Schmiedeberg's Archives of Pharmacology. 291: 89-100. DOI: 10.1007/BF00510823  1
1975 Glossmann H, Klapettek K. Adrenal cortex adenylate cyclase - Specific binding sites for 5′-guanylyl-imidodiphosphate in partially purified plasma membranes from bovine adrenal cortex Naunyn-Schmiedeberg's Archives of Pharmacology. 289: 99-109. DOI: 10.1007/BF00498032  1
1975 Glossmann H. Regulatory nucleotide binding sites for adrenal cortex adenylate cyclase Naunyn.Schmied.Arch.Pharm.. 287: R49.  1
1974 Neville DM, Glossmann H. Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate. Methods in Enzymology. 32: 92-102. PMID 4444547 DOI: 10.1016/0076-6879(74)32012-5  1
1973 Marx SJ, Woodward C, Aurbach GD, Glossmann H, Keutmann HT. Renal receptors for calcitonin. Binding and degradation of hormone. The Journal of Biological Chemistry. 248: 4797-802. PMID 4718745  1
Show low-probability matches.